arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

ImageneBio, Inc.

IMA

$5.61 ▲ +0.13 (+2.37%) at close

7 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

ImageneBio, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $27.3M

Dividend Yield —

Revenue Growth -77.1% ↘

Op. Margin None

ROIC -36.1% ↘

FCF / Share $-9.82 ↗

Trailing P/E —

Price / Book 0.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$800.00K

↓ -77.1% —

Net Income Profit after all expenses

$-45.35M

↓ -24.0% —

Operating Margin Operating profit as % of sales

-454.0%

↓ -312.1% —

FCF / Share Free cash flow per share

$-9.82

↑ +45.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	-77.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1064%)	-61.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-872%)	-41.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-617%)	-49.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-720%)	237.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2863%)	—	—
EPS Growth YoY (%)	56.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-1255.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	14.2% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	-55.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—
Net Income Growth YoY (%)	-24.0% Weak ↓ Weak Declining Year-over-year change in net income	46.4% Excellent ↑ Excellent Improving Year-over-year change in net income	0.9% Caution ↑ Caution Improving Year-over-year change in net income	-101.6% Weak Weak Year-over-year change in net income	22.9% Good Good Year-over-year change in net income	—	—
FCF Growth YoY (%)	45.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-829.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	8.0% Fair Fair Year-over-year change in free cash flow	5.8% Fair Fair Year-over-year change in free cash flow	—	—	—
Revenue CAGR 3Y (%)	-62.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-51.7% Weak Weak Compound annual revenue growth over 3 years	-0.1% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	-38.6% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	—	—	—	-454.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3127%)	-110.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-835%)	-484.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3328%)	—
Effective Tax Rate (%) (%)	0.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
Profit Margin (%) (%)	—	—	—	-440.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3769%)	-110.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1018%)	-481.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4111%)	—
FCF Margin (%) (%)	—	—	—	-483.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-200.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-419.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	1.06x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.18x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.10x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.82x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-36.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	23.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-44.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-38.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	34.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-31.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-232.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-39.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-41.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-26.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-34.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-327%)	22.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+52%)	-40.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-368%)	-46.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-412%)	-16.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-209%)	43.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+192%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Net Debt (USD)	$-94.53M	$-12.12M	$-119.89M	$-59.92M	$-232.22M	$-162.49M	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$0.16	$2.93	$0.22	$0.43	$1.11	—	—
Basic EPS, GAAP (USD)	$-9.64	$-22.10	$-1.63	$-1.90	$-1.22	—	—
Free Cash Flow per Share (USD)	$-9.82	$-17.85	$-1.92	$-2.09	$-2.22	—	—
Book Value per Share (USD)	$27.33	$-134.46	$3.52	$4.05	$5.78	$-32.63	—
Tangible Book Value per Share (USD)	$27.33	$-134.46	$3.52	$4.05	$5.78	$-32.63	—
Basic Weighted Avg Shares (shares)	4.87M	1.19M	41.74M	36.19M	27.98M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$129.05M	$-4.74M	$164.46M	$138.51M	$209.33M	$137.64M	—
Total Equity (USD)	$133.14M	$-160.56M	$169.76M	$146.97M	$207.88M	$-101.05M	$-61.46M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$800.00K	$3.50M	$9.16M	$15.62M	$30.98M	$9.19M	—
Depreciation Expense (USD)	$400.00K	$1.10M	$1.02M	$751.00K	$544.00K	$300.00K	—
Net Income, GAAP (USD)	$-45.35M	$-36.57M	$-68.17M	$-68.77M	$-34.12M	$-44.26M	—
Operating Cash Flow (USD)	$-47.84M	$-21.32M	$-79.74M	$-74.11M	$-60.25M	$-37.83M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

ImageneBio, Inc.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare IMA with peers